Skip to content

Clinical trials

Completed Phase 3 Insulin Resistance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 3 Status: Completed Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20032
20043
20055
20067
20072
20083
20098
20105
201112
20124
20136
20144
20152
20164
20174
20182
20194
20201
20211
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed95

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanabe Pharma Corporation5
Geropharm4
Population Health Research Institute4
Sanwa Kagaku Kenkyusho Co., Ltd.3
Ain Shams University2
AstraZeneca2
Biodel2
Brigham and Women's Hospital2
Gan and Lee Pharmaceuticals, USA2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance95
Diabetes Mellitus, Type 233
Diabetes Mellitus29
Diabetes Mellitus, Type 112
Obesity12
Cardiovascular Diseases6
Glucose Intolerance6
Hyperglycemia5
Polycystic Ovary Syndrome5
Diabetes, Gestational4

Trials

Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.